Bizily Scott's Form 4 filing
4D Molecular Therapeutics, Inc. (FDMT) · filed Mar 29, 2024
- Accession no.
- 0000950170-24-038731
- Filed
- Mar 29, 2024
- Trade date
- Mar 27, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $204.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bizily ScottCIK 0001920738 | Officer (Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 27, 2024 | Common Stock | MOption exerciseAcquired | +4,342 | $25.98 | +$112,805.16 | 6,079 | Direct | |
| Mar 27, 2024 | Common Stock | MOption exerciseAcquired | +1,491 | $25.98 | +$38,736.18 | 7,570 | Direct | |
| Mar 27, 2024 | Common Stock | SSaleDisposed | −5,833 | $35.04 | −$204,388.32 | 1,737 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 27, 2024 | Common Stock | MOption exerciseDisposed | −4,342 | $0.00 | $0 | 55,658 | Direct | |
| Mar 27, 2024 | Common Stock | MOption exerciseDisposed | −1,491 | $0.00 | $0 | 54,167 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.